SG102892G - Composition of pregnanolole comprising a stable oil-in-water emulsion - Google Patents

Composition of pregnanolole comprising a stable oil-in-water emulsion

Info

Publication number
SG102892G
SG102892G SG1028/92A SG102892A SG102892G SG 102892 G SG102892 G SG 102892G SG 1028/92 A SG1028/92 A SG 1028/92A SG 102892 A SG102892 A SG 102892A SG 102892 G SG102892 G SG 102892G
Authority
SG
Singapore
Prior art keywords
composition
water emulsion
pregnanolole
stable oil
pregnanolone
Prior art date
Application number
SG1028/92A
Other languages
English (en)
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of SG102892G publication Critical patent/SG102892G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
SG1028/92A 1986-02-13 1992-10-07 Composition of pregnanolole comprising a stable oil-in-water emulsion SG102892G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
SG102892G true SG102892G (en) 1992-12-04

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1028/92A SG102892G (en) 1986-02-13 1992-10-07 Composition of pregnanolole comprising a stable oil-in-water emulsion

Country Status (14)

Country Link
US (1) US5028600A (fr)
EP (1) EP0233849B1 (fr)
JP (1) JPH0788305B2 (fr)
AT (1) ATE64526T1 (fr)
CA (1) CA1301651C (fr)
DE (1) DE3770830D1 (fr)
DK (1) DK175504B1 (fr)
ES (1) ES2037742T3 (fr)
FI (1) FI88676C (fr)
GR (1) GR3002299T3 (fr)
HK (1) HK83293A (fr)
NO (1) NO175040B (fr)
SE (1) SE8600632D0 (fr)
SG (1) SG102892G (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
WO1999007381A1 (fr) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions et traitements permettant de reduire les effets secondaires lies a l'administration des precurseurs de la testosterone androgenique
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
EP1539104A2 (fr) * 2000-12-29 2005-06-15 The Trustees Of Columbia University In The City Of New York Utilisation de iv emulsions composees de differents triglycerides, de differentes taille de particules, et d'apolipoproteines e, pour l'administration de composes hydrophobes a des tissus cibles
MXPA04012756A (es) * 2002-07-02 2005-03-23 Altana Pharma Ag Suspension acuosa esteril que contiene ciclesonida.
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2006030450A2 (fr) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Compositions d'emulsions stables destinees a l'administration intraveineuse et presentant une efficacite de conservation
WO2012096697A1 (fr) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Procédés et compositions pour le traitement de maladies liées à un manque de réserve de sang, à un choc et à des lésions neuronales
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
SMT202000008T1 (it) 2012-01-23 2020-03-13 Sage Therapeutics Inc Formulazione di steroide neuroattivo comprendente un complesso di allopregnanolone e solfobutil eter beta-ciclodestrina
WO2014028398A2 (fr) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation de crises épileptiques par une polythérapie à l'aide de benzodiazépines et de neurostéroïdes
PL2887944T3 (pl) 2012-08-21 2022-02-21 Sage Therapeutics, Inc. Allopregnanolon do leczenia lekoopornego stanu padaczkowego
ES2973320T3 (es) 2012-11-30 2024-06-19 Univ California Alopregnanolona para tratar, reducir o mitigar los síntomas de la depresión posparto
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
RU2766155C2 (ru) 2016-03-08 2022-02-08 Сейдж Терапьютикс, Инк. Нейроактивные стероиды, их композиции и применения
AU2019396217A1 (en) * 2018-12-10 2021-07-08 Halo Science LLC Stable formulations of anesthetics and associated dosage forms
CA3151334C (fr) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Formulations topiques de neurostereoide
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US12186327B2 (en) 2022-08-29 2025-01-07 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
GR3002299T3 (en) 1992-12-30
DK175504B1 (da) 2004-11-15
JPH0788305B2 (ja) 1995-09-27
FI870589L (fi) 1987-08-14
EP0233849A1 (fr) 1987-08-26
FI870589A0 (fi) 1987-02-12
SE8600632D0 (sv) 1986-02-13
NO870560D0 (no) 1987-02-12
ATE64526T1 (de) 1991-07-15
US5028600A (en) 1991-07-02
FI88676C (fi) 1993-06-28
EP0233849B1 (fr) 1991-06-19
NO175040C (fr) 1994-08-24
ES2037742T3 (es) 1993-07-01
DK62187D0 (da) 1987-02-06
DK62187A (da) 1987-08-14
CA1301651C (fr) 1992-05-26
FI88676B (fi) 1993-03-15
NO175040B (no) 1994-05-16
DE3770830D1 (de) 1991-07-25
NO870560L (no) 1987-08-14
JPS62192322A (ja) 1987-08-22
HK83293A (en) 1993-08-20

Similar Documents

Publication Publication Date Title
NO175040C (fr)
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ES8504678A1 (es) Procedimiento para la preparacion de un derivado de insulina
DE3564566D1 (en) Quinone derivatives, method and use of preparing same, and pharmaceutical composition
MY101784A (en) Novel pharmacological compounds
WO1987006226A3 (fr) Derives d'azacycloalkane, activateurs d'absorption contenant ces derives en tant qu'ingredients efficaces, et preparations externes contenant lesdits activateurs d'absorption
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
FR2688499B1 (fr) Procede de preparation de la beta-phenylisoserine et de ses analogues.
FI910653A0 (fi) Synteettiset reseptorianalogit
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
DE69018730D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
SE8403268L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES471507A1 (es) Procedimiento para la obtencion de piperidino-propanoles
ES8609315A1 (es) Procedimiento para preparar derivados de 3,4 diazol
AU1459192A (en) Aminoacyl derivatives of gem-diphosphonic acids, a process for the preparation thereof and pharmaceutical compositions containing them
ES8303324A1 (es) "procedimiento para preparar una sustancia activa adecuada para la estabilizacion de prostaglandinas y sus derivados".
EP0260606A3 (fr) Médicament contenant du sialocylglycérolipide pour guérir des troubles ou des maladies neurotiques
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
UA16000A1 (uk) Спосіб лікуваhhя гіпотрофії поросят
KR890001582A (ko) 향류머티스제
JO1531B1 (en) New near-compounds